Member Info for 86KB

Imm once use to trade in pounds.

Dallo have a look at this link, mentions imm are trading SETS

https://www.londonstockexchange.com/stock/IMM/immupharma-plc/company-page

IMM is SETS trading so no mms involved. But it could also be Lanstead selling and warrants.

Tiger you got to understand the share price rose from 0.8s to 4.8p. Profit taking would be expected hence we have dropped yet still we are holding over 250% from the lows. You have to go back and do some reading and ask yourself why you bought in the first place and then you will be confident in your investment.

Well it could still get to them figures may take abit longer, more collabs and deals once they have presented at the conference. The reason why it fell from ipo 40p is because there were sellers and overtime it may well get there again. Profit taking was expected.

Im seeing blue on my screen 4.69%

Expecting news for warrants cleared, Lanstead out and licensing deals.

They have been in discussions since last year with lots of interest and now its about getting the licensing deals. Remember they have had significant interest from global pharmas and the autoimmune therapies are in high demand.

The advances made by ImmuPharma with the P140 program, particularly in the latter part of 2024, have led to significant interest from leading Biopharmaceutical companies and we are progressing discussions as we move to establish global licensing agreements.

Seems like background buying taking place as taking it up on every trade

Https://www.fiercepharma.com/pharma/jpm25-day-1-fierce-pharma-daily-roundup

This link has some updates about conference

Deals have been made during the conference and hopefully we get something about licensing deals too.

This link has some updates on what has been going on

https://www.fiercepharma.com/pharma/jpm25-day-1-fierce-pharma-daily-roundup

Looks like its ready to move back up

Profit taking done next wave up, we filled the first gap at 5.1 next gap is at 9.2p. mcap is tiny and we have less than 70m shares available.

Next wave we head towards 8p, we have event today so probably get some more interest.

Morning shake we go back up again, try buying lol

Large addressable markets of chronic and mental health conditions and Inflammatory Bowel Disease (IBD), representing respectively over $3 trillion and $30-50 Billion total annual costs in the US.

No dilution since ipo

Ipo was 40p went up to 78p

Summary and Highlights:

· Successful Fundraising for gross proceeds of £28.5 million

· Issue price per Trellus Share of 40 pence

· The Fundraising was significantly oversubscribed across all components, raising the following amounts in gross proceeds:

− the Placing (c. £25.2 million)

− the Subscription (c. £2.4 million)

− the Restricted Offer (c. £0.9 million)

· Market capitalisation of approximately £64.6 million on Admission

· Enlarged Share Capital on Admission of 161,475,000 Ordinary Shares

They have a strong cash balance which will keep them going until Q3 long time. Plus todays deal with upfront payments and monthly payments says they dont need no cash for awhile. Further deals and they wont need to raise at all.